ALLMedicine™ Autoimmune Polyglandular Syndrome Type 1 Center
Research & Reviews 71 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814426
BMC Medical Genomics; Ruan J, Wang X et. al.
Jan 20th, 2021 - Pure red cell aplasia (PRCA) and large granular lymphocytic leukaemia (LGLL) are very rare complications of autoimmune polyendocrine syndrome type 1 (APS1). Here, we report a case of APS1 with PRCA and LGLL. Previous cases were reviewed, and possi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792334
BMC Ophthalmology; Wu PY, Chang HW et. al.
Jan 8th, 2021 - Autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive disease. In patients with APS-1, the most frequently reported ocular manifestations are keratoconjunctivitis with dry eye and retinal degeneration. However, to our know...
https://doi.org/10.1210/clinem/dgaa881
The Journal of Clinical Endocrinology and Metabolism; Capalbo D, Moracas C et. al.
Nov 28th, 2020 - Primary adrenal insufficiency (PAI) is a rare and potentially life-threatening condition that is poorly characterized in children. To describe causes, presentation, auxological outcome, frequency of adrenal crisis and mortality of a large cohort o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579748
The American Journal of Case Reports; Ennab RM, Saadeh NA
Oct 17th, 2020 - BACKGROUND Autoimmune polyglandular syndrome type 1 (APS-1) is an extremely rare autoimmune disorder with an autosomal recessive inheritance pattern. Its manifestations present in chronological sequence of the components mucocutaneous candidiasis,...
https://doi.org/10.1007/s40618-020-01376-5 10.1007/978-3-319-73082-0_1-1 10.1016/j.autrev.2010.08.019 10.4049/jimmunol.1100212 10.1515/jpem.2005.18.2.155 10.1111/j.1365-3083.2010.02397.x 10.1016/j.jaci.2005.08.036 10.4049/jimmunol.178.2.1208 10.1016/j.imbio.2016.09.001 10.1210/jcem.78.2.8106620 10.1016/j.imlet.2009.04.001 10.1016/j.molimm.2015.06.026 10.1210/jc.2012-2734 10.1056/NEJMoa0706487 10.1210/jc.2008-0935 10.1084/jem.20091983 10.1210/edrv.23.3.0466 10.1210/jc.2005-2611 10.1016/j.autrev.2017.11.012 10.1056/NEJMra1713301 10.1007/s40619-016-0169-y 10.1210/jc.2011-2461 10.1172/jci.insight.88782 10.1016/j.clim.2018.06.012 10.1111/j.1365-2796.2009.02090.x 10.1590/s0004-27302012000100009 10.3390/ijms17071106 10.1056/NEJM199006283222601 10.1210/jcem.81.4.8636356 10.1002/humu.1178 10.1111/j.1365-2133.2006.07166.x 10.1111/j.1399-0004.2009.01278.x 10.1016/S0140-6736(97)11050-9 10.1210/jc.2002-021761 10.4103/ijpd.ijpd_20_17 10.1111/j.1365-2265.2008.03318.x 10.1210/jcem.87.2.8209 10.1159/000363537 10.7754/Clin.Lab.2012.120803 10.3275/7677 10.1210/jcem.86.10.7884 10.1016/j.immuni.2015.04.021 10.1530/EJE-07-0843 10.1210/jcem.87.6.8564 10.1007/s11154-018-9467-y 10.1038/s41575-019-0242-7 10.4049/jimmunol.1502465 10.3390/ijms20020283 10.4103/0378-6323.152285 10.4103/2156-7514.103018 10.1515/jpem-2012-0201 10.1515/jpem.2003.16.1.103 10.1111/j.1399-0004.2009.01280.x 10.1530/EC-17-0022 10.1007/s12098-013-1201-x 10.4103/0974-7753.125624 10.1515/jpem.2010.23.3.271 10.1111/cen.13111
Journal of Endocrinological Investigation; Fierabracci A, Arena A et. al.
Aug 8th, 2020 - Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) or autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive genetic disease due to mutations in the AIRE (AutoImmune REgulator) gene. The clinical diagno...
Clinicaltrials.gov 73 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814426
BMC Medical Genomics; Ruan J, Wang X et. al.
Jan 20th, 2021 - Pure red cell aplasia (PRCA) and large granular lymphocytic leukaemia (LGLL) are very rare complications of autoimmune polyendocrine syndrome type 1 (APS1). Here, we report a case of APS1 with PRCA and LGLL. Previous cases were reviewed, and possi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792334
BMC Ophthalmology; Wu PY, Chang HW et. al.
Jan 8th, 2021 - Autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive disease. In patients with APS-1, the most frequently reported ocular manifestations are keratoconjunctivitis with dry eye and retinal degeneration. However, to our know...
https://doi.org/10.1210/clinem/dgaa881
The Journal of Clinical Endocrinology and Metabolism; Capalbo D, Moracas C et. al.
Nov 28th, 2020 - Primary adrenal insufficiency (PAI) is a rare and potentially life-threatening condition that is poorly characterized in children. To describe causes, presentation, auxological outcome, frequency of adrenal crisis and mortality of a large cohort o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579748
The American Journal of Case Reports; Ennab RM, Saadeh NA
Oct 17th, 2020 - BACKGROUND Autoimmune polyglandular syndrome type 1 (APS-1) is an extremely rare autoimmune disorder with an autosomal recessive inheritance pattern. Its manifestations present in chronological sequence of the components mucocutaneous candidiasis,...
https://doi.org/10.1007/s40618-020-01376-5 10.1007/978-3-319-73082-0_1-1 10.1016/j.autrev.2010.08.019 10.4049/jimmunol.1100212 10.1515/jpem.2005.18.2.155 10.1111/j.1365-3083.2010.02397.x 10.1016/j.jaci.2005.08.036 10.4049/jimmunol.178.2.1208 10.1016/j.imbio.2016.09.001 10.1210/jcem.78.2.8106620 10.1016/j.imlet.2009.04.001 10.1016/j.molimm.2015.06.026 10.1210/jc.2012-2734 10.1056/NEJMoa0706487 10.1210/jc.2008-0935 10.1084/jem.20091983 10.1210/edrv.23.3.0466 10.1210/jc.2005-2611 10.1016/j.autrev.2017.11.012 10.1056/NEJMra1713301 10.1007/s40619-016-0169-y 10.1210/jc.2011-2461 10.1172/jci.insight.88782 10.1016/j.clim.2018.06.012 10.1111/j.1365-2796.2009.02090.x 10.1590/s0004-27302012000100009 10.3390/ijms17071106 10.1056/NEJM199006283222601 10.1210/jcem.81.4.8636356 10.1002/humu.1178 10.1111/j.1365-2133.2006.07166.x 10.1111/j.1399-0004.2009.01278.x 10.1016/S0140-6736(97)11050-9 10.1210/jc.2002-021761 10.4103/ijpd.ijpd_20_17 10.1111/j.1365-2265.2008.03318.x 10.1210/jcem.87.2.8209 10.1159/000363537 10.7754/Clin.Lab.2012.120803 10.3275/7677 10.1210/jcem.86.10.7884 10.1016/j.immuni.2015.04.021 10.1530/EJE-07-0843 10.1210/jcem.87.6.8564 10.1007/s11154-018-9467-y 10.1038/s41575-019-0242-7 10.4049/jimmunol.1502465 10.3390/ijms20020283 10.4103/0378-6323.152285 10.4103/2156-7514.103018 10.1515/jpem-2012-0201 10.1515/jpem.2003.16.1.103 10.1111/j.1399-0004.2009.01280.x 10.1530/EC-17-0022 10.1007/s12098-013-1201-x 10.4103/0974-7753.125624 10.1515/jpem.2010.23.3.271 10.1111/cen.13111
Journal of Endocrinological Investigation; Fierabracci A, Arena A et. al.
Aug 8th, 2020 - Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) or autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive genetic disease due to mutations in the AIRE (AutoImmune REgulator) gene. The clinical diagno...
News 4 results
https://www.medscape.com/viewarticle/916258
Jul 30th, 2019 - A group of scientists from leading institutions is questioning the findings of a prominent immunology article linked to a strategic drug development partnership potentially worth up to €164 million ($183 million). The original article, published i...
https://www.mdedge.com/neurology/article/116220/rare-diseases/october-21-deadline-nord-research-grant-abstracts
Oct 1st, 2016 - The deadline has been extended to October 21 to submit letters of intent and abstracts for National Organization for Rare Disorders (NORD) research grants for studies related to the following rare diseases: Alveolar capillary dysplasia with misali.
https://www.mdedge.com/familymedicine/article/113266/rare-diseases/nord-announces-2016-grant-opportunities
Neurology Reviews;
Sep 1st, 2016 - NORD has announced its 2016 requests for proposals for research studies related to the following rare diseases: Alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV) Appendix cancer and pseudomyxoma peritonei (PMP) Autoim.
https://www.mdedge.com/familymedicine/article/101039/rare-diseases/nord-announces-rare-disease-research-funding
Cardiology News;
Jul 6th, 2015 - The National Organization for Rare Disorders (NORD) has posted requests for proposals (RFPs) for grants to support research on several rare diseases. July 31, 2015, will be the deadline to submit abstracts and letters of intent.